Or. Admin. R. 333-024-0260 - Purpose

Current through Register Vol. 61, No. 4, April 1, 2022

(1) OAR 333-024-0260 through 333-024-0265 shall apply to the assay of Maternal Serum Alpha-Fetoprotein (MSAFP), Amniotic Fluid Alpha-Fetoprotein (AFAFP), Serum Human Chorionic Gonadotropin, Unconjugated Estriol, Amniotic Fluid Acetylcholinesterase or other related markers for the purposes of congenital/genetic screening.
(2) All sections of Clinical Laboratory OAR 333-024-0005 through 333-024-0055 shall apply.

Notes

Or. Admin. R. 333-024-0260
HD 28-1988, f. & cert. ef. 12-7-88; HD 6-1995, f. & cert. ef. 9-13-95

Stat. Auth.: ORS 438.320

Stats. Implemented: ORS 438.320

The following state regulations pages link to this page.



State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.